| Product Name | MF | CAS | Details |
|---|
| BIS THF HNS Derivative 2 | C11H13NO7 | 799241-85-3 | Details |
| Captopril EP Impurity A (Captopril Disulfide) | Details |
| Captopril EP Impurity G | C6H10O3S | 33325-40-5 | Details |
| Captopril Related Compound 5 | C6H9ClO2S | 74345-73-6 | Details |
| Captopril Impurity 1 | C9H15NO4 | 613256-52-3 | Details |
| Captopril Related Compound 10 | C14H22N2O6S2 | 78636-31-4 | Details |
| Bendamustine Impurity G;(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate | Details |
| BIS THF HNS Derivative 1 | C11H13NO7 | 253265-98-4 | Details |
| BIS THF Nitro Derivative 2 | C13H13NO7 | 252873-01-1 | Details |
| BIS THF Nitro Derivative 1 | C13H13NO7 | 288296-64-0 | Details |
| Bendamustine Impurity D;ethyl 4-(5-(bis(2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoate | Details |
| Tacrolimus EP Impurity A | C43H69NO12 | 104987-12-4 | Details |
| Atropine Sulfate | 2C17H23NO3.H2O4S | 55-48-1 | Details |
| Azilsartan iMpurity G | C22H22N4O3 | Details |
| Bendamustine Impurity A;4-(5-((2-chloroethyl)amino)-1-methyl-1H-benzo[d]imidazol-2-yl)butanoic acid | Br- | 109882-26-0 | Details |
| BIS THF HNS Derivative 3 | C11H13NO7 | 799241-86-4 | Details |
| Bupropion Impurity B HCl | C13H19BrClNO | 1049718-43-5 | Details |
| Captopril Impurity F | C9H15NO3S | 63250-36-2 | Details |
| Hydroxy Bupropion | C13H18ClNO2 | 357399-43-0 | Details |
| Bupropion impurity 16 | C9H9ClO | 34841-35-5 | Details |
| Bupropion Indandione | C9H7ClO2 | 10557-17-2 | Details |
| Captopril EP Impurity G | C6H10O3S | 76497-39-7 | Details |
| BIS THF Nitro Derivative 3 | C6H10O3 | 252873-00-0 | Details |
| Bupropion Impurity 12 HCl | C13H18ClNO | 1346598-72-8 | Details |
| Valsartan Methyl Ester | C12H14ClNO3S | 2133460-42-9 | Details |
| Bupropion impurity 15 | C7H5ClO2 | 535-80-8 | Details |
| Riluzole Impurity 5 | C7H4Br2F3NO | 88149-49-9 | Details |
| Bupropion Impurity 3 | C13H19NO | 34509-36-9 | Details |
| Bupropion impurity A HCl | C13H19Cl2NO | 1049718-72-0 | Details |
| Bupropion impurity F | C9H9ClO2 | 857233-13-7 | Details |
| Bupropion Related Compound C | C9H9ClO2 | 152943-33-4 | Details |
| Bupropion Morpholinol-d6 | C13H18ClNO2 | 1216893-18-3 | Details |
| Captopril Related Compound 7 | C11H17NO4S | 65167-28-4 | Details |
| Captopril Related Compound 6 | C6H9ClO2S | 69570-39-4 | Details |
| Captopril EP Impurity J | C11H17NO4S | 64838-55-7 | Details |
| Bupropion-d9 HCl | C13H10Cl2D9NO | 1189725-26-5 | Details |
| Valsartan Methyl Ester | C12H14ClNO3S | 2133460-43-0 | Details |
| Apixaban Impurity 82 | C26H25ClN4O4 | Details |
| Darunavir Ethanolate | C29H43N3O8S | 635728-49-3 | Details |
| Darunavir Impurity 10 | C7H10O4 | 1932330-83-0 | Details |
| Dapoxetine impurity 37 | C9H9ClO | 936-59-4 | Details |
| Cinacalcet impurity 7 | C22H23ClF3N | 1428118-39-1 | Details |
| Clozapine EP Impurity C | C17H17ClN4 | 6104-71-8 | Details |
| Glycine impurity 11 | C9H10ClNO2 | 532987-11-4 | Details |
| Cinacalcet impurity 21;N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide hydrochloride | Details |
| Clozapine EP Impurity C-d8 (N-Desmethyl Clozapine-d8) | C18H18ClN4 | 1185053-50-2 | Details |
| Clozapine EP Impurity C-d8 (N-Desmethyl Clozapine-d8) | C18H15ClD4N4 | 204395-52-8 | Details |
| Clopidogrel Metabolite 1;(E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-mercaptopiperidin-3-ylidene)acetic acid | Details |
| Cinacalcet impurity 20;N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propanamide hydrochloride | Details |
| Cinacalcet impurity 18;(E)-N-(1-(5,6-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide hydrochloride | C22H24F3N | 802918-35-0 | Details |
| Captopril Related Compound 9 | C12H20N2O5S2 | 75479-46-8 | Details |
| Captopril-d3 | C9H15NO3S | 1356383-38-4 | Details |
| Cinacalcet impurity 22;(E)-N-(1-(5,6,7,8-tetrahydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)acrylamide hydrochloride | Details |
| Clevidipine Butyrate Impurity 9;3-((butyryloxy)methyl) 5-methyl 4-(3,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | C22H25Cl2NO6 | Details |
| Clozapine-5-N-Glucuronide Sodium Salt | C24H27ClN4O6 | 390651-03-3 | Details |
| Creatine Phosphate Sodium Impurity 9;2-(3-(bis(benzyloxy)phosphoryl)-1-methylguanidino)acetic acid | C4H8N3Na2O5P | Details |
| Dilinavir | C27H37N3O7S | 206361-99-1 | Details |
| Clozapine EP Impurity A | C13H9ClN2O | 50892-62-1 | Details |
| Clopidogrel Bisulfate Impurity 33 | C16H16ClNO5S2 | 2173294-69-2 | Details |
| Darunavir Impurity 11 | C7H10O4 | 1932353-11-1 | Details |
| Darunavir Impurity 12 | C7H10O4 | 866594-60-7 | Details |
| Darunavir Impurity 13 | C11H19NO6 | 156636-67-8 | Details |
| Darunavir Impurity 14 | C22H30N2O3 | 143224-62-8 | Details |
| Cefoperazone impurity 30. | C25H28N9NaO8S2 | 62893-20-3 | Details |
| Clozapine-d3 | C18H19ClN4 | 1215691-72-7 | Details |
| Creatine Phosphate Sodium Impurity 3;2-(3-cyano-1-methylguanidino)acetic acid | C4H8N3Na2O5P | Details |
| Creatine Phosphate Sodium Impurity 8;benzyl hydrogen (1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)phosphoramidate | C4H8N3Na2O5P | Details |
| Creatine Phosphate Sodium Impurity 1; sodium N-methylcarbamimidoylphosphoramidate | C4H8N3Na2O5P | Details |
| Creatine Phosphate Sodium Impurity 13;dibenzyl (1-methyl-4-oxoimidazolidin-2-ylidene)phosphoramidate | C4H8N3Na2O5P | Details |
| Creatine Phosphate Sodium Impurity 10;2-(3-((benzyloxy)(hydroxy)phosphoryl)-1-methylguanidino)acetic acid | C4H8N3Na2O5P | Details |
| Darunavir Impurity 15 | C21H27N3O4S | 1418639-27-6 | Details |
| Argatroban iMpurity J | Details |
| Darunavir Impurity 19 | C20H29N3O3S | 1402142-62-4 | Details |
| Captopril EP Impurity N | C8H14O4S2 | 65134-74-9 | Details |
| Captopril EP Impurity D | C4H7BrO2 | 56970-78-6 | Details |
| Clopidogrel Impurity 2;5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-6,7-dihydrothieno[3,2-c]pyridin-5-ium bromide | C15H14ClNO2S | Details |
| Clopidogrel Impurity 1;5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium chloride | C15H14ClNO2S | Details |
| Captopril | C9H15NO3S | 62571-86-2 | Details |
| Glycine impurity 10 | C9H10ClNO2 | 43189-20-4 | Details |
| C9H12ClNO2 | Details |
| C8H8ClNO2 | Details |
| Cleviprex Impurity 8 | C15H13Cl2NO4 | Details |
| Clopidogrel Impurity 49 | C6H8OS | 5402-55-1 | Details |
| (R)-N-(1-(naphthalen-2-yl)ethyl) | C29H28F3NO2S | Details |
| Dabigatran Etexilate iMpurity K | Details |
| Dabigatran Etexilate iMpurity Q | Details |
| Dabigatran Etexilate iMpurity P | Details |
| Bupropion impurity M1-9 | C9H8BrClO | 34911-51-8 | Details |
| Captopril EP Impurity C | C4H8O2S | 26473-47-2 | Details |
| Argatroban iMpurity I | C23H36N6O5S | Details |
| Bupropion Impurity 13 | C13H18Cl3NO | 1346603-00-6 | Details |
| Argatroban iMpurity L | C23H36N6O5S | Details |
| Argatroban iMpurity H | Details |
| Argatroban iMpurity K | Details |
| Azilsartan iMpurity M | Details |
| Azilsartan Impurity M | C22H17N3O4 | 2244031-86-3 | Details |
| Conivaptan impurity F | C32H26N4O2 | Details |
| Captopril EP Impurity H | C15H23NO5S2 | 205521-07-9 | Details |
| Captopril Impurity 2 | C9H15NO3S | 112243-88-6 | Details |
| Darunavir Impurity 2 | C22H31N3O5S | 1526916-57-3 | Details |
| Product Total： Product Page： | ||||
| 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 | ||||